Avista Capital Partners, a healthcare-focused private equity shop, has appointed Patrick O’Neill, formerly of Johnson & Johnson, as an industry advisor.
O'Neill joined Johnson & Johnson in 1976 and retired in 2006. Along the way, he held research and development and new business development positions in the pharmaceutical business at the company.
“We believe that as the healthcare industry continues to grow, investment opportunities in the medical device and pharmaceutical sector—and companies servicing these fields—are well-positioned to benefit from the aging of the population and the continued advancement in medical technologies,” said David Burgstahler, partner. “Pat’s deep experience and expertise in both the med device and pharma sector make him an invaluable addition to our team as we manage our large and growing portfolio of healthcare companies and as we evaluate new investments in this industry.”
Avista Capital was founded in 2005 and has offices in New York and Houston.
Genna GarverBy Genna Garver, John Brunjes, and Cheri Hoff of Bracewell & Giuliani -- On Oct. 27 the Private Fund Investment Advisers Registration Act of 2009 (H.R. 3818) moved one step closer to becoming law with the 67-1 approval of the U.S. House of Representatives Committee on Financial Services (the "Bill"). More...
Investors this week announced the formation of NewWorld Capital Group, a private equity firm that will invest in middle-market companies and related infrastructure projects in the cleantech sphere. More...